1. Home
  2. CNEY vs EVGN Comparison

CNEY vs EVGN Comparison

Compare CNEY & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CN Energy Group Inc.

CNEY

CN Energy Group Inc.

HOLD

Current Price

$0.44

Market Cap

5.9M

Sector

Industrials

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.43

Market Cap

5.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNEY
EVGN
Founded
2009
1999
Country
China
Israel
Employees
N/A
52
Industry
Major Chemicals
Agricultural Chemicals
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
5.3M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
CNEY
EVGN
Price
$0.44
$0.43
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
743.9K
467.2K
Earning Date
02-13-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$73.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.37
52 Week High
$2.95
$1.50

Technical Indicators

Market Signals
Indicator
CNEY
EVGN
Relative Strength Index (RSI) 33.35 28.23
Support Level $0.32 N/A
Resistance Level $1.04 $0.86
Average True Range (ATR) 0.14 0.04
MACD -0.03 -0.00
Stochastic Oscillator 16.68 26.09

Price Performance

Historical Comparison
CNEY
EVGN

About CNEY CN Energy Group Inc.

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: